Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine.
BACK TO LIST

Laboratory Report

Patient
Name: Porzio, , Vincenza,
DOB: 13-SEP-1965 (Age: 60)
Gender: female
Address:
Piazza Allegra, 720
36040 Grumolo Pedemonte (Italy)
ID: 9988-341158-1 (ECI)
Report
Date: 13-MAR-2025
Laboratory
dr Ample, Ex
Laboratoire Central Européenne
Boulevard du Jardin Botanique 32
1000 Brussels (Belgium)
Requested by
Villa Margherita
(Italy)
Specimen
Collected: 13-MAR-2025

Chemistry

Test 13-MAR-2025 Reference Range Unit
Hemoglobin A1c/Hemoglobin.total in Blood 5.9 4 - 6 %
Glucose [Mass/volume] in Blood 85.2 70 - 140 mg/dL
Urea nitrogen [Mass/volume] in Blood 7.2 7 - 25 mg/dL
Creatinine [Mass/volume] in Blood 0.7 0.6 - 1.1 mg/dL
Calcium [Mass/volume] in Blood 8.9 8.5 - 10.4 mg/dL
Sodium [Moles/volume] in Blood 141.7 135 - 145 mmol/L
Potassium [Moles/volume] in Blood 3.9 3.5 - 5.1 mmol/L
Chloride [Moles/volume] in Blood 103.1 98 - 108 mmol/L
Carbon dioxide, total [Moles/volume] in Blood 28.9 22 - 29 mmol/L

Annotation

Conclusion and Recommendations based on this report and previous findings known to us
All measured parameters are within normal limits. Glycemic control (HbA1c, glucose) is adequate, and renal function (urea, creatinine), electrolytes, and calcium are normal. No laboratory evidence of metabolic or renal dysfunction at this time. Recommend routine follow-up as clinically indicated.